MRP: ₹2995
₹2372
₹ 623 Off
(Incl. of all taxes)
Qty
Buying in bulk?
In stock
Deliver to
- 7-day returns
- Secure payment
- International shipping
- Carefully packed
Get this at ₹ 2253Extra 5% OffAdd items worth ₹999 to the cart & get extra 5% off
Get this at ₹ 2135Extra 10% OffAdd items worth ₹1499 to the cart & get extra 10% off
Book Summary
About the Book: Medicinal Marine Life: Anti-Tubercular Compounds
Tuberculosis (TB), caused by Mycobacterium tuberculosis (M. tb), continues to
be a global health burden and it remains the leading cause of death from a
single infectious agent after COVID-19. According to the WHO (2025), an
estimated 1.25 million deaths were attributed to TB in 2024 alone. It is
estimated that nearly one-quarter of the global population carries latent M. tb
infection, and approximately 510% of these individuals will develop active TB
during their lifetime. Multidrug-resistant tuberculosis (MDR-TB), characterized
by resistance to the two most effective first-line drugs viz. isoniazid and
rifampin; and extensively drug-resistant tuberculosis (XDR-TB), which exhibits
additional
- ISBN-13
- 9789368643197
- Language
- English
- Binding
- Hard Bound
- Publisher
- SBS Publishers and Distributors Pvt. Ltd.
- Publishing Date
- 2027
- Total Pages
- 193
Medicinal Marine Life: Anti-Tubercular Compounds
Frequently bought together
Total for 3 items₹2498₹3135You save ₹637
Product Specifications
Book Summary
About the Book: Medicinal Marine Life: Anti-Tubercular Compounds
Tuberculosis (TB), caused by Mycobacterium tuberculosis (M. tb), continues to
be a global health burden and it remains the leading cause of death from a
single infectious agent after COVID-19. According to the WHO (2025), an
estimated 1.25 million deaths were attributed to TB in 2024 alone. It is
estimated that nearly one-quarter of the global population carries latent M. tb
infection, and approximately 510% of these individuals will develop active TB
during their lifetime. Multidrug-resistant tuberculosis (MDR-TB), characterized
by resistance to the two most effective first-line drugs viz. isoniazid and
rifampin; and extensively drug-resistant tuberculosis (XDR-TB), which exhibits
additional
Book Specifications
- ISBN-13
- 9789368643197
- Language
- English
- Binding
- Hard Bound
- Publisher
- SBS Publishers and Distributors Pvt. Ltd.
- Publishing Date
- 2027
- Total Pages
- 193